Stocktoria

Medline Inc. MDLN

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-12-17 · LEI

Medline Inc. statistics & valuation

Market cap$51.1B
P / E44.1×
P / S1.8×
P / B2.6×
P / FCF39.4×
Net margin4.1%
Return on equity6.0%
FCF margin4.6%
Net debt$10.5B
Net debt / EBITDA3.3×
Enterprise value USD$61.6B
EV / EBITDA19.1×
Earnings yield EBIT/EV3.6%
Return on capital6.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
4.10% 20242025
Gross margin (%)
27.30% 26.40% 20242025
Operating margin (%)
8.40% 7.80% 20242025
Return on equity (%)
6.00% 20242025
Shares outstanding
810.0M 20242025
Net debt ($)
$16.22B $10.54B 20242025
Share buybacks ($)
20242025
Return on assets (%)
3.00% 20242025
Free cash flow margin (%)
5.50% 4.60% 20242025
Debt / equity (×)
0.65× 20242025
EPS ($)
-$0.01 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Gross margin26.4%27.3%
Operating margin7.8%8.4%
Net margin4.1%—
FCF margin4.6%5.5%
Return on assets3.0%—
Return on equity6.0%—
Debt / equity0.65×—
Current ratio4.293.39

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.